Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.

Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, Carvalho AF, Leite CC, Busatto GF, Zarate CA Jr, Gattaz WF.

J Clin Psychopharmacol. 2016 Nov 28. [Epub ahead of print]

PMID:
27902528
2.

GSK-3: a key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput.

Zarate CA Jr, Machado-Vieira R.

Bipolar Disord. 2016 Nov 29. doi: 10.1111/bdi.12452. [Epub ahead of print] No abstract available.

PMID:
27900801
3.

Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.

Park M, Newman LE, Gold PW, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CA Jr.

J Psychiatr Res. 2017 Jan;84:113-118. doi: 10.1016/j.jpsychires.2016.09.025.

PMID:
27718369
4.

Update on bipolar disorder biomarker candidates.

Teixeira AL, Salem H, Frey BN, Barbosa IG, Machado-Vieira R.

Expert Rev Mol Diagn. 2016 Nov;16(11):1209-1220.

PMID:
27737600
5.

Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.

Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA Jr, Machado-Vieira R.

Expert Rev Clin Pharmacol. 2016 Oct 26. [Epub ahead of print]

PMID:
27781556
6.

Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study.

Machado-Vieira R, Luckenbaugh DA, Ballard ED, Henter ID, Tohen M, Suppes T, Zarate CA Jr.

Am J Psychiatry. 2016 Aug 13:appiajp201615091132. [Epub ahead of print]

PMID:
27523498
7.

Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.

de Sousa RT, Loch AA, Carvalho AF, Brunoni AR, Haddad MR, Henter ID, Zarate CA, Machado-Vieira R.

Neuropsychopharmacology. 2016 Sep 28. doi: 10.1038/npp.2016.149. [Epub ahead of print] Review.

PMID:
27510426
8.

Familial aggregation and heritability of the melancholic and atypical subtypes of depression.

Lamers F, Cui L, Hickie IB, Roca C, Machado-Vieira R, Zarate CA Jr, Merikangas KR.

J Affect Disord. 2016 Nov 1;204:241-6. doi: 10.1016/j.jad.2016.06.040.

PMID:
27450632
9.

Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study.

Ballard ED, Vande Voort JL, Luckenbaugh DA, Machado-Vieira R, Tohen M, Zarate CA.

Bipolar Disord. 2016 Jun;18(4):363-72. doi: 10.1111/bdi.12397.

PMID:
27233466
10.

Bias in emerging biomarkers for bipolar disorder.

Carvalho AF, Köhler CA, Fernandes BS, Quevedo J, Miskowiak KW, Brunoni AR, Machado-Vieira R, Maes M, Vieta E, Berk M.

Psychol Med. 2016 Aug;46(11):2287-97. doi: 10.1017/S0033291716000957.

PMID:
27193198
11.

Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial.

Siqueira CC, Valiengo LL, Carvalho AF, Santos-Silva PR, Missio G, de Sousa RT, Di Natale G, Gattaz WF, Moreno RA, Machado-Vieira R.

PLoS One. 2016 May 6;11(5):e0154195. doi: 10.1371/journal.pone.0154195.

12.

Corrigendum: Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype.

Zimmer ER, Torrez VR, Kalinine E, Augustin MC, Zenki KC, Almeida RF, Hansel G, Muller AP, Souza DO, Machado-Vieira R, Portela LV.

Front Cell Neurosci. 2016 Apr 11;10:93. doi: 10.3389/fncel.2016.00093.

13.

The role of adipokines in the rapid antidepressant effects of ketamine.

Machado-Vieira R, Gold PW, Luckenbaugh DA, Ballard ED, Richards EM, Henter ID, De Sousa RT, Niciu MJ, Yuan P, Zarate CA Jr.

Mol Psychiatry. 2016 Apr 5. doi: 10.1038/mp.2016.36. [Epub ahead of print]

PMID:
27046644
14.

Evidence for increased motor cortical facilitation and decreased inhibition in atypical depression.

Veronezi BP, Moffa AH, Carvalho AF, Galhardoni R, Simis M, Benseñor IM, Lotufo PA, Machado-Vieira R, Daskalakis ZJ, Brunoni AR.

Acta Psychiatr Scand. 2016 Aug;134(2):172-82. doi: 10.1111/acps.12565.

PMID:
27028276
15.

THERAPEUTIC MODULATION OF GLUTAMATE RECEPTORS IN MAJOR DEPRESSIVE DISORDER.

Jaso BA, Niciu MJ, Iadarola ND, Lally N, Richards EM, Park M, Ballard ED, Nugent AC, Machado-Vieira R, Zarate CA Jr.

Curr Neuropharmacol. 2016 Mar 21. [Epub ahead of print]

PMID:
26997505
16.

Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.

Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZ, Stella F, Machado-Vieira R, Gattaz WF.

Bipolar Disord. 2016 Feb;18(1):63-70. doi: 10.1111/bdi.12360.

PMID:
26876913
17.

An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.

Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA Jr.

J Affect Disord. 2016 Apr;194:115-9. doi: 10.1016/j.jad.2016.01.009.

PMID:
26807672
18.

Quantifying the influence of child abuse history on the cardinal symptoms of fibromyalgia.

Ortiz R, Ballard ED, Machado-Vieira R, Saligan LN, Walitt B.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S59-66.

PMID:
26743156
19.

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

Richards EM, Mathews DC, Luckenbaugh DA, Ionescu DF, Machado-Vieira R, Niciu MJ, Duncan WC, Nolan NM, Franco-Chaves JA, Hudzik T, Maciag C, Li S, Cross A, Smith MA, Zarate CA Jr.

Psychopharmacology (Berl). 2016 Mar;233(6):1119-30. doi: 10.1007/s00213-015-4195-4.

20.

New targets for rapid antidepressant action.

Machado-Vieira R, Henter ID, Zarate CA Jr.

Prog Neurobiol. 2015 Dec 23. pii: S0301-0082(15)30038-1. doi: 10.1016/j.pneurobio.2015.12.001. [Epub ahead of print] Review.

PMID:
26724279
Items per page

Supplemental Content

Loading ...
Support Center